These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36073648)

  • 1. Nonadherence by Serum Drug Analyses in Resistant Hypertension: 7-Year Follow-Up of Patients Considered Adherent by Directly Observed Therapy.
    Halvorsen LV; Bergland OU; Søraas CL; Larstorp ACK; Hjørnholm U; Kjær VN; Kringen MK; Clasen PE; Haldsrud R; Kjeldsen SE; Rostrup M; Fadl Elmula FEM; Opdal MS; Høieggen A
    J Am Heart Assoc; 2022 Sep; 11(18):e025879. PubMed ID: 36073648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.
    Azizi M; Pereira H; Hamdidouche I; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Véhier C; Courand PY; Lantelme P; Denolle T; Dourmap-Collas C; Girerd X; Michel Halimi J; Zannad F; Ormezzano O; Vaïsse B; Herpin D; Ribstein J; Chamontin B; Mourad JJ; Ferrari E; Plouin PF; Jullien V; Sapoval M; Chatellier G;
    Circulation; 2016 Sep; 134(12):847-57. PubMed ID: 27576780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients.
    Hamdidouche I; Jullien V; Boutouyrie P; Billaud E; Azizi M; Laurent S
    J Hypertens; 2017 Sep; 35(9):1891-1898. PubMed ID: 28505066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonadherence to antihypertensive medications is related to pill burden in apparent treatment-resistant hypertensive individuals.
    Lawson AJ; Hameed MA; Brown R; Cappuccio FP; George S; Hinton T; Kapil V; Lenart J; Lobo MD; Martin U; Menon M; Nightingale A; Rylance PB; Webb DJ; Dasgupta I
    J Hypertens; 2020 Jun; 38(6):1165-1173. PubMed ID: 32371807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of adherence to treatment in patients with resistant hypertension using toxicological serum analysis. A subgroup evaluation of the RESIST-POL study.
    Florczak E; Tokarczyk B; Warchoł-Celińska E; Szwench-Pietrasz E; Prejbisz A; Gosk M; Kabat M; Narkiewicz K; Januszewicz A; Kała M
    Pol Arch Med Wewn; 2015; 125(1-2):65-72. PubMed ID: 25578261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinic Versus Ambulatory Blood Pressure in Resistant Hypertension: Impact of Antihypertensive Medication Nonadherence: A Post Hoc Analysis the DENERHTN Study.
    Hamdidouche I; Gosse P; Cremer A; Lorthioir A; Delsart P; Courand PY; Denolle T; Halimi JM; Girerd X; Ormezzano O; Rossignol P; Pereira H; Azizi M;
    Hypertension; 2019 Nov; 74(5):1096-1103. PubMed ID: 31995406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical Screening for Nonadherence Is Associated With Blood Pressure Reduction and Improvement in Adherence.
    Gupta P; Patel P; Štrauch B; Lai FY; Akbarov A; Gulsin GS; Beech A; Marešová V; Topham PS; Stanley A; Thurston H; Smith PR; Horne R; Widimský J; Keavney B; Heagerty A; Samani NJ; Williams B; Tomaszewski M
    Hypertension; 2017 Nov; 70(5):1042-1048. PubMed ID: 28847892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence.
    Siddiqui M; Judd EK; Dudenbostel T; Zhang B; Gupta P; Tomaszewski M; Patel P; Oparil S; Calhoun DA
    Hypertension; 2019 Sep; 74(3):652-659. PubMed ID: 31327263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial.
    de Jager RL; van Maarseveen EM; Bots ML; Blankestijn PJ;
    Br J Clin Pharmacol; 2018 Jan; 84(1):18-24. PubMed ID: 28815689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
    Ewen S; Meyer MR; Cremers B; Laufs U; Helfer AG; Linz D; Kindermann I; Ukena C; Burnier M; Wagenpfeil S; Maurer HH; Böhm M; Mahfoud F
    Clin Res Cardiol; 2015 Dec; 104(12):1097-105. PubMed ID: 26306594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.
    Fadl Elmula FE; Hoffmann P; Fossum E; Brekke M; Gjønnæss E; Hjørnholm U; Kjær VN; Rostrup M; Kjeldsen SE; Os I; Stenehjem AE; Høieggen A
    Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistant hypertension? Assessment of adherence by toxicological urine analysis.
    Jung O; Gechter JL; Wunder C; Paulke A; Bartel C; Geiger H; Toennes SW
    J Hypertens; 2013 Apr; 31(4):766-74. PubMed ID: 23337469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonadherence to antihypertensive medications amongst patients with uncontrolled hypertension: A retrospective study.
    Kulkarni S; Rao R; Goodman JDH; Connolly K; O'Shaughnessy KM
    Medicine (Baltimore); 2021 Apr; 100(14):e24654. PubMed ID: 33832064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing Adherence to Antihypertensive Medication by Means of Dose-Dependent Reference Plasma Concentration Ranges and Ultra-High Performance Liquid Chromatography-Ion Trap Mass Spectrometry Analysis.
    Wagmann L; Vollmer AC; Lauder L; Mahfoud F; Meyer MR
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33803489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical approach for measurement of antihypertensive medication adherence in patients with resistant hypertension.
    Corrêa NB; de Faria AP; Ritter AM; Sabbatini AR; Almeida A; Brunelli V; Calhoun DA; Moreno H; Modolo R
    J Am Soc Hypertens; 2016 Jun; 10(6):510-516.e1. PubMed ID: 27161936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive Medication Adherence and Confirmation of True Refractory Hypertension.
    Siddiqui M; Judd EK; Dudenbostel T; Gupta P; Tomaszewski M; Patel P; Oparil S; Calhoun DA
    Hypertension; 2020 Feb; 75(2):510-515. PubMed ID: 31813346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Drug Monitoring to Assess Drug Adherence in Assumed Resistant Hypertension: A Comparison With Directly Observed Therapy in 3 Nonadherent Patients.
    Feyz L; Bahmany S; Daemen J; van den Meiracker AH; Koch BCP; van Gelder T; Versmissen J
    J Cardiovasc Pharmacol; 2018 Aug; 72(2):117-120. PubMed ID: 29878936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis.
    Durand H; Hayes P; Morrissey EC; Newell J; Casey M; Murphy AW; Molloy GJ
    J Hypertens; 2017 Dec; 35(12):2346-2357. PubMed ID: 28777133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Kronish IM; Lynch AI; Oparil S; Whittle J; Davis BR; Simpson LM; Krousel-Wood M; Cushman WC; Chang TI; Muntner P
    Hypertension; 2016 Jul; 68(1):39-45. PubMed ID: 27217410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor Adherence to Statin and Antihypertensive Therapies as Risk Factors for Fatal Stroke.
    Herttua K; Martikainen P; Batty GD; Kivimäki M
    J Am Coll Cardiol; 2016 Apr; 67(13):1507-1515. PubMed ID: 27150680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.